小孩子的旋律与机械膜替换:单中心倾向匹配分析
Morgan K Moroi1, Alice V Vinogradsky1, Iris Feng1
1Section of Pediatric and Congenital Cardiac Surgery, Department of Surgery, NewYork Presbyterian-Morgan Stanley Children's Hospital, New York, NY.
The Annals of thoracic surgery
|August 27, 2025
概括
在幼儿中,MVR是一种可行的机械MVR替代方案,在不需要全身抗凝治疗的情况下显示出相似的存活率和重新干预率.
科学领域:
- 儿童心脏病学
- 心血管外科
- 生物材料科学
背景情况:
- 在幼儿中进行关节置换 (MVR) 具有独特的挑战.
- 比较假体门的选择对于优化患者的治疗结果至关重要.
研究的目的:
- 在2岁以下的儿科患者中,比较Melody门与机械门置换的结果.
- 在两组中评估无移植生存率和重新干预的必要性.
主要方法:
- 对36名接受Melody或机械MVR治疗的患者 (<2年) 的回顾性评估.
- 倾向性得分匹配创建了两个12名患者的组.
- 在2. 3年的中位随访期内比较无移植存活率和重复手术的累积发病率.
主要成果:
- 没有显著的差异在5年后的无移植生存率 (66. 7% Melody vs. 66. 0% Mechanical) 或在2年后的重新干预 (32. 2% Melody vs.
- 早期手术重新干预的比例相似 (两组均为16. 7%).
- 在机械组中需要更高的起器 (36.4%对0%,P=0.08).
结论:
- 在幼儿中,旋律MVR是机械MVR的合适替代品.
- 在两种门类型之间观察到可比的中期发病率和死亡率.
- 这种门避免了全身抗凝剂的需要,这对于儿科患者来说是一个显著的优势.
相关概念视频
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Regurgitation I: Introduction
55
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55
Mitral Regurgitation III: Medical Management
28
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
28
Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Valve Prolapse I: Introduction
42
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
42


